Hepatitis c donor livers safely transplanted into healthy recipients
NCT ID NCT03819322
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether livers from donors with hepatitis C could be safely transplanted into people without hepatitis C. Five patients on the liver transplant waiting list received these livers and were then treated with an antiviral drug to prevent infection. The goal was to see if this approach could expand the donor pool and reduce wait times.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END STAGE LIVER DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UPMC
Pittsburgh, Pennsylvania, 15213, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can personalized antibiotics outsmart resistant bacteria in liver transplants?
- Can immune cells predict herpesvirus danger in transplant patients?
- A Finger-Prick could change the fight against hepatitis c
- A simple finger prick could transform hepatitis c care
- Can coaching clinics curb HIV? a new strategy puts it to the test
- Muscle quality on MRI may foretell liver transplant success